It is important to bear in mind that these figures relate to the quantity of products prescribed within four years, not the amount of patients that have received a prescription for CBPMs. But (there is a large disparity between the estimated current figures of patient eligibility), and the amount of patients actually able to access these medicines in the UK. (more…)